These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36477632)

  • 1. Super-selective transcatheter vesical arterial chemoembolization with drug-loaded beads for muscle-invasive bladder cancer with hematuria.
    Zhou Y; Chen J; Chen P; Tang Y; Wu S; Cai S; Fang Z
    Abdom Radiol (NY); 2023 Feb; 48(2):780-786. PubMed ID: 36477632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short-term efficacy and safety of callispheres drug-loaded microsphere embolization in primary hepatocellular carcinoma.
    Li J; Wang N; Shi C; Liu Q; Song J; Ye X
    J Cancer Res Ther; 2021 Jul; 17(3):733-739. PubMed ID: 34269307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of doxorubicin-eluting CalliSpheres® beads-transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.
    Bi Y; Shi X; Ren J; Yi M; Han X; Song M
    BMC Gastroenterol; 2021 May; 21(1):231. PubMed ID: 34020608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical evaluation of oxaliplatin-loaded drug-eluting callispheres beads transarterial chemoembolization for unresectable or recurrent esophageal carcinoma.
    Bi Y; Ren J; Han X
    World J Surg Oncol; 2024 Oct; 22(1):272. PubMed ID: 39390475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CalliSpheres drug-eluting beads versus lipiodol transarterial chemoembolization in the treatment of hepatocellular carcinoma: a short-term efficacy and safety study.
    Wu B; Zhou J; Ling G; Zhu D; Long Q
    World J Surg Oncol; 2018 Mar; 16(1):69. PubMed ID: 29587773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.
    Xiang H; Long L; Yao Y; Fang Z; Zhang Z; Zhang Y
    Technol Cancer Res Treat; 2019 Jan; 18():1533033819830751. PubMed ID: 30862264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Super-selective transarterial chemoembolization of hepatocellular carcinoma with doxorubicin-eluting beads sized 40-75 microns: assessment of efficacy and safety.
    Ballı HT; Aikimbaev K
    Diagn Interv Radiol; 2020 Sep; 26(5):482-487. PubMed ID: 32815520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization by CalliSpheres
    Sun J; Zhou G; Xie X; Gu W; Huang J; Zhu D; Hu W; Hou Q; Shi C; Li T; Zhang X; Ji W; Ying S; Peng Z; Zhou J; Yu Z; Ji J; Du H; Guo X; Fang J; Han J; Xu H; Sun Z; Yu W; Shao G; Wu X; Hu H; Li L; Zheng J; Luo J; Chen Y; Cao G; Hu T
    Oncol Res; 2020 Feb; 28(1):75-94. PubMed ID: 31558180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial chemoembolization with doxorubicin-loaded beads for inoperable or recurrent colorectal cancer.
    Bi Y; Shi X; Ren J; Yi M; Han X; Song M
    Abdom Radiol (NY); 2021 Jun; 46(6):2833-2838. PubMed ID: 33386908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancer.
    Wang MQ; Zhang JL; Duan F; Yuan B; Xin H; Fu JX; Ye HY; Yu HK; Feng DP; Cheng K; Zhang XJ
    Prostate Cancer Prostatic Dis; 2023 Mar; 26(1):88-95. PubMed ID: 35249108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conventional Versus Small Doxorubicin-eluting Bead Transcatheter Arterial Chemoembolization for Treating Barcelona Clinic Liver Cancer Stage 0/A Hepatocellular Carcinoma.
    Kang YJ; Lee BC; Kim JK; Yim NY; Kim HO; Cho SB; Jeong YY
    Cardiovasc Intervent Radiol; 2020 Jan; 43(1):55-64. PubMed ID: 31646378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epirubicin-loaded beads transarterial prostatic arterial chemoembolization is a promising treatment for advanced prostate cancer with lower urinary tract obstruction or hematuria-a case series report.
    Guan Y; Wang W; Zhang T; Liao L; Chen J; Zhang Z; Chen N; Zeng G
    Transl Androl Urol; 2022 Apr; 11(4):480-494. PubMed ID: 35558269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The efficacy of drug-eluting beads bronchial arterial chemoembolization loaded with gemcitabine for treatment of non-small cell lung cancer.
    Bie Z; Li Y; Li B; Wang D; Li L; Li X
    Thorac Cancer; 2019 Sep; 10(9):1770-1778. PubMed ID: 31321919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching the loaded agent from epirubicin to cisplatin: salvage transcatheter arterial chemoembolization with drug-eluting microspheres for unresectable hepatocellular carcinoma.
    Seki A; Hori S
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):555-62. PubMed ID: 21562932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year outcome of conventional and drug-eluting transcatheter arterial chemoembolization in patients with hepatocellular carcinoma.
    Liu YS; Lin CY; Chuang MT; Lin CY; Tsai YS; Wang CK; Ou MC
    BMC Gastroenterol; 2018 Aug; 18(1):124. PubMed ID: 30075752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term efficacy of transarterial chemoembolization with epirubicin-loaded superabsorbent polymer microspheres for hepatocellular carcinoma: comparison with conventional transarterial chemoembolization.
    Morimoto M; Kobayashi S; Moriya S; Ueno M; Tezuka S; Irie K; Goda Y; Ohkawa S
    Abdom Radiol (NY); 2017 Feb; 42(2):612-619. PubMed ID: 27624498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging Changes and Clinical Complications After Drug-Eluting Bead Versus Conventional Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma: Multicenter Study.
    Zhang L; Sun JH; Ji JS; Zhong BY; Zhou GH; Song JJ; Hou ZH; Huang P; Zhang S; Li Z; Zhu XL; Ni CF
    AJR Am J Roentgenol; 2021 Oct; 217(4):933-943. PubMed ID: 33245680
    [No Abstract]   [Full Text] [Related]  

  • 18. Pirarubicin-loaded CalliSpheres® drug-eluting beads for the treatment of patients with stage III-IV lung cancer.
    Bi Y; Shi X; Yi M; Han X; Ren J
    Acta Radiol; 2022 Mar; 63(3):311-318. PubMed ID: 33615822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preliminary outcomes of raltitrexed eluting bead-transarterial chemoembolization using Callispheres® beads for gastrointestinal adenocarcinoma liver metastasis.
    Bi Y; Jiao D; Wang Y; Han X; Ren J
    World J Surg Oncol; 2022 Jul; 20(1):229. PubMed ID: 35821043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical outcomes of uterine arterial chemoembolization with drug-eluting beads for advanced-stage or recurrent cervical cancer.
    Bi Y; Wang Y; Zhang J; Shi X; Wang Y; Xu M; Han X; Ren J
    Abdom Radiol (NY); 2021 Dec; 46(12):5715-5722. PubMed ID: 34476534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.